Site Map
Posts
- Category: Wp Feeds (continued)
- Estrogen Guards Against Effects of Fatty Liver
- European Agency Favors Remicade Biosimilars
- Evidence-Based Medicine Loses a Round in Federal Court
- Ex Vivo Surgery Works on Complex Tumors (CME/CE)
- Excerpt: Black Man in a White Coat
- Excess Sugar Not Directly Tied to Liver Disease (CME/CE)
- Exercise and Cancer Risk: Cancer Network and OncoTherapy News
- Exercise Has Small Benefit in Liver Disease (CME/CE)
- Exercise May Boost Survival in CRC: Gastro and Endo News Report
- Exercise May Extend Survival in Metastatic Colon Cancer
- Exercise Tied to Gut Microbiome Diversity
- Experience of Surgeon Key in Choice of Hernia Repair Technique (CME/CE)
- Expert: More Oversight Needed for Health Facility Safety
- Experts Raise Red Flag over Fatty Liver Disease
- Experts Raise Red Flag over Fatty Liver Disease
- Experts Respond to Latest Aspirin Findings
- Experts Tackle Rx Drug Spending
- Experts Weigh In on Expanded Lap-Band Indication
- Experts Weigh In on IgG4 Disease (CME/CE)
- Experts: Restrictive Sharing Policies Have No Place at Medical Meetings
- Exploding Colonoscopy Patients: That's Improbable!
- Extended Lymph Node Excision Feasible in Gastric Cancer
- Extra Drug Hikes HCV Regimen's Efficacy (CME/CE)
- Extreme Exercise Tied to Gut Damage
- Failed HBV Vaccine Still Protects Kids (CME/CE)
- Family History Links 'Unrelated' Cancers (CME/CE)
- Fatty Liver Disease on Rise in Teens (CME/CE, with video)
- Fatty Liver Tied to Diabetes, Atherosclerosis
- Fatty Liver Ups Risk for Liver Cancer (CME/CE)
- Fatty Liver: Vitamin D Deficiency Is Common Comorbidity (CME/CE)
- Fauci Faces Questions; Benefits of 'Dry January'; Resort Linked With Legionnaires
- Fauci Grilled by Subcommittee; Vaccine Sales Plunge; Nanoplastics in Water
- Fauci Will Accept Pardon; RFK Jr. and COVID Vaccines; Nursing Director Shot
- Fauci's Pardon: 'It's Really a Shame,' Public Health Officials Say
- FDA Adds GI Warning to Benicar Label
- FDA Adds More Warnings for Lipitor, Crestor, and Zocor
- FDA Advisers Down on OTC Combos For Tummy Trouble
- FDA Advisory Panel Splits on Second DMD Drug
- FDA Aims To Improve Off-Label Use: Gastro and Endo News Report
- FDA Announces New Blood Donation Policy for MSM
- FDA Approves Advanced Pancreatic Cancer Tx
- FDA Approves Everolimus for Liver Rejection
- FDA Approves HCV Drug Combo for All Genotypes
- FDA Approves HCV Drugs for Ages 12-17
- FDA Approves Humira Biosimilar
- FDA Approves Infliximab Biosimilar, Inflectra
- FDA Approves New HCV Combo Pill, 8-Week Regimen
- FDA Approves Novavax COVID-19 Shot, but With Unusual Restrictions
- FDA Backs Down on Fecal Transplant Rules
- FDA Backs Off on Endoscope Recall
